US$11.4 Billion Deal: Innovent Biologics (Xìn Dá Shēng Wù 信达生物, 01801.HK) and Takeda (Wǔ Tián Zhì Yào 武田制药) Announce Global BD Collaboration to Co‑develop Three Oncology Candidates

China Finance China Startups, , , ,
October 22, 2025